Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Metabolics Pharma is a clinical-stage biopharmaceutical company based in Doylestown, PA, focused on developing innovative treatments for metabolic diseases such as obesity, type 2 diabetes, and MASH. Its lead candidate, ENT-03, is a centrally acting aminosterol that targets Protein Tyrosine Phosphatase 1B (PTP1B) to improve insulin sensitivity and support sustained weight loss. Backed by a team of experienced professionals, Me...
Metabolics Pharma is a clinical-stage biopharmaceutical company based in Doylestown, PA, focused on developing innovative treatments for metabolic diseases such as obesity, type 2 diabetes, and MASH. Its lead candidate, ENT-03, is a centrally acting aminosterol that targets Protein Tyrosine Phosphatase 1B (PTP1B) to improve insulin sensitivity and support sustained weight loss. Backed by a team of experienced professionals, Metabolics Pharma aims to transform the treatment landscape for metabolic disorders through science-driven innovation.

List your booth number for exhibitions, ask us